Rosa Negash
Overview
Explore the profile of Rosa Negash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crossnohere N, Campoamor N, Negash R, Wood M, Studts J, Elsaid M, et al.
Cancer Control
. 2024 Oct;
31:10732748241291609.
PMID: 39397323
Background: Multi-cancer early detection tests (MCEDs) have the potential to identify over 50 types of cancer from a blood sample, possibly transforming cancer screening paradigms. Studies on the safety and...
2.
Negash R, Li E, Jacque N, Novicoff W, Evans S
Front Vet Sci
. 2024 Jul;
11:1377207.
PMID: 38988986
Introduction: Feline Infectious Peritonitis (FIP) has historically been a fatal coronavirus disease in cats. In recent years, the therapeutic agent GS-441524, developed by Gilead Sciences, was found to be a...
3.
Negash R, Baselice H, Srinivas S, Chawla M, Young A
J Surg Res
. 2023 Dec;
295:332-339.
PMID: 38061238
Introduction: Blunt cerebrovascular injury (BCVI) is defined as a nonpenetrating injury to the carotid or vertebral arteries which can be highly morbid. Because BCVI is rare, most studies have been...
4.
Chawla M, Baselice H, Negash R, Helkin A, Young A
J Surg Res
. 2023 Oct;
294:58-65.
PMID: 37864960
Introduction: Older adults experience higher rates of complications after an emergency exploratory laparotomy (EEL). To better understand the shift to an aging population in the United States, identifying how age...
5.
Roy M, Jacque N, Novicoff W, Li E, Negash R, Evans S
Pathogens
. 2022 Oct;
11(10).
PMID: 36297266
Feline infectious peritonitis (FIP) is a complex and historically fatal disease, though recent advances in antiviral therapy have uncovered potential treatments. A newer therapeutic option, unlicensed molnupiravir, is being used...